Home Newsfeeds JP Morgan Downgrades Offerpad Solutions to Neutral

JP Morgan Downgrades Offerpad Solutions to Neutral

JP Morgan analyst Dae Lee downgrades Offerpad Solutions (NYSE:OPAD) from Overweight to Neutral.

byBenzinga Newsdesk

March 8, 2023

1 minute read

JP Morgan analyst Dae Lee downgrades Offerpad Solutions (NYSE:OPAD) from Overweight to Neutral.

Study Of TNG260 And An Anti-PD Antibody In STK11 Mutated Solid Tumors

By Happy Mohamed

June 2, 10:50 AM

https://clinicaltrials.gov/ct2/show/NCT05887492 Brief Summary: The goal of this interventional clinical trial is to learn about TNG260, a CoREST inhibitor, in combination with pembrolizumab in patients with

TNGX

Stephens & Co. Maintains Overweight on Flywire, Lowers Price Target to $26

By Benzinga Newsdesk

November 9, 11:19 AM

Stephens & Co. analyst Charles Nabhan maintains Flywire (NASDAQ:FLYW) with a Overweight and lowers the price target from $30 to $26.

FLYW

What’s Going On With Target Shares

By Henry Khederian

October 18, 1:41 PM

Target Corporation (NYSE: TGT) shares are trading higher by 4.87% to $156.52 during Tuesday's session after Jefferies upgraded the stock from Hold to Buy and raised its price target from $170 to $185.

TGT

News

Casa Systems Sets Cable Industry Milestone With DOCSIS 4.0 Extended Spectrum Breakthrough

By Benzinga Newsdesk

November 21, 9:31 AM

Groundbreaking performance marks Casa Systems' vCCAP and RPD as key innovators in cable technology virtualizationFull utilization of extended spectrum DOCSIS accelerates cable operator's path to 10GCasa Systems'

CASA

JP Morgan Downgrades Offerpad Solutions to Neutral

Related Posts

Study Of TNG260 And An Anti-PD Antibody In STK11 Mutated Solid Tumors

Stephens & Co. Maintains Overweight on Flywire, Lowers Price Target to $26

What’s Going On With Target Shares

Casa Systems Sets Cable Industry Milestone With DOCSIS 4.0 Extended Spectrum Breakthrough